November 24, 2017

Periodic update on transaction details related to Philips’ share repurchases

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported the transaction details related to the repurchases of its own common shares made in the period from November 17, 2017 up to and including November 23, 2017. These repurchases were made under the repurchase program to cover long-term incentive and employee share purchase plans, which was announced on October 30, 2017. With these transactions, Philips has now completed this repurchase program. Further details can be found in the table below and via this link.*
Date
Total number of repurchased shares
Weighted average purchase price (EUR)
November 17, 2017
505,000
33.27
November 20, 2017
205,000
32.97
November 21, 2017
33,713
33.06
November 22, 2017
395,390
33.32
November 23, 2017
78,609
33.24
* In parallel, Philips is conducting the EUR 1.5 billion share buyback program for capital reduction purposes, which was announced on June 28, 2017. Details about these transactions can be found via this link

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Read MoreRead Less

Topics

Contacts

Ben Zwirs

Ben Zwirs

Philips Group Press Office

Tel: +31 6 1521 3446

Ksenija Gonciarenko

Ksenija Gonciarenko

Philips Investor Relations

Tel: +31 20 59 77055

Press releases

Get our press releases by e-mail

Share on social media